Skip to content

This website is a third-party information service. It does not provide medical care or operate a treatment facility.

Colorectal Phase 2 Trials

Tampa, Florida

Phase 2 colorectal cancer trials in Tampa, FL

5 Phase 2 colorectal cancer studies are recruiting participants at sites in Tampa as of November 18, 2026, according to ClinicalTrials.gov. Colorectal Phase 2 Trials can help you understand your options and connect with a study team.

Call (888) 467-9061
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Tampa at a glance

  • 5 studies are recruiting at a site in Tampa.
  • By phase: Phase 2 (5).
  • By sponsor: industry (4), university, hospital or other (1).
  • Most recent update to one of these records: November 18, 2026.

Studies recruiting in Tampa

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Verastem, Inc.
    Study site
    Moffitt Cancer Center
    Registry record
    NCT07659795 · updated
  2. FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Oncolytics Biotech
    Study site
    Moffitt Cancer Center
    Registry record
    NCT07446322 · updated
  3. Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Delcath Systems Inc.
    Study site
    Moffitt Cancer Center
    Registry record
    NCT06607458 · updated
  4. A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    AbbVie
    Study site
    Moffitt Cancer Center /ID# 274372
    Registry record
    NCT07023289 · updated
  5. Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    H. Lee Moffitt Cancer Center and Research Institute
    Study site
    Moffitt Cancer Center
    Registry record
    NCT06553885 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Tampa, FL on ClinicalTrials.gov.

Ask about studies near Tampa

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Florida

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 2, as each study is coded in the registry.

Colorectal Phase 2 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 467-9061

or send a short form

How should we reach you?

Call